HOME >> MEDICINE >> NEWS
Wellcome brain insights

Determining how the brain develops and functions is one of the greatest questions facing scientists today. A researcher in the newly formed section of ophthalmology and neuroscience has been awarded a four year Wellcome Trust career development fellowship worth over half a million pounds to study a congenital brain disease and shed light on one of the most important processes in embryonic development.

Dr Jacquelyn Bond is investigating a genetic disorder called microcephaly, which causes babies to be born with a small brain and mental retardation. Dr Bond and colleagues from the unit have already pinned down several genes which, when defective, cause microcephaly. She is now studying one of these genes, ASPM, to find its function and to determine how defects in the gene cause microcephaly.

Dr Bond believes that the ASPM protein is involved in cell division in the brain. Knowing how it works is not only of medical interest but could also tell us about the evolution of the human brain, the organ that makes us unique in the animal kingdom. "Functional studies of this important gene will increase our understanding of the pathways involved in brain development and determine how aberrations in the pathway involving ASPM result in microcephaly," said Dr Bond.

Other groups in the section of ophthalmology and neuroscience work on inherited blindness (Professor Chris Inglehearn) the molecular mechanisms which cause Parkinson's diseases (Dr Phil Robinson and Dr Helen Ardley) and the possible involvement of microcephaly genes in cancer (Dr Sandra Bell). Recent successes for the group include awards to Dr Carmel Toomes of a Royal Society principle research fellowship to study retinal vascular disease, and to Dr Manir Ali of an MRC new investigator award to study inherited blindness in chickens.


'"/>

Contact: Hannah Love
pressoffice@leeds.ac.uk
44-113-343-4100
University of Leeds
1-Mar-2006


Page: 1

Related medicine news :

1. The Burroughs Wellcome Fund awards $8 million to infectious disease investigators
2. Draining away brains toxic protein to stop Alzheimers
3. New research discovers independent brain networks control human walking
4. ADHD appears to be associated with depressed dopamine activity in the brain
5. First of its kind report on how children with brain tumors perform at school
6. Chemical in brain acts like a fuel gauge
7. Case study: cross-cultural bioethics training program helps fight African brain drain
8. Paying taxes, according to the brain, can bring satisfaction
9. Childrens brain responses predict impact of sleep loss on attention
10. Old memory traces in brain may trigger chronic pain
11. Stanford researchers track human stem cells transplanted into rat brain

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Wellcome brain insights

(Date:6/18/2013)... (PRWEB) June 19, 2013 Looking for a ... monotony of everyday life? , IWALKAWAKE is a guide ... Written by Adam Botha, it focuses on harnessing the powerful ... The book lays out a nine-step guide to finding one’s ... that a person must go through to reach their true ...
(Date:6/18/2013)... Daily Gossip Magazine has always kept its readers entertained ... , The magazine has decided to prepare readers for the ... recipe every week . , According to Daily Gossip ... readers who are looking to get insights into this type ... anabolic food is almost entirely based on healthy, yet tasteful ...
(Date:6/18/2013)... (PRWEB) June 18, 2013 SEATTLE, WA—A ... Farms of Fairview, Oregon, claiming he fell ill with ... berry and pomegranate seed blend. The complaint was ... by Marler Clark, the Seattle-based law firm that has ... , According to the complaint, Brian Brothers consumed “Townsend ...
(Date:6/18/2013)... Warner, NH (PRWEB) June 18, 2013 ... rugged, submersible, battery powered, stand-alone device which can be ... The new stainless steel enclosure of the Temp1000IS comes ... device interfaces with the IFC400 (sold separately) ... docking station for full communications. No more removal of ...
(Date:6/18/2013)... Senior drug regulatory officials from mainland China and Taiwan ... first time in the U.S.—the need for more collaboration between ... in a timely manner. Representatives from the Taiwan and mainland ... and processes in drug review during the Convergence in ... DIA 2013 49th Annual Meeting . , While ...
Breaking Medicine News(10 mins):Health News:Anabolic Cooking Book Review Exposes Dave Ruel’s Top 10 ‘Anabolicious’ Recipes for BodyBuilders 2Health News:Marler Clark, Washington Resident Sue Townsend Farms Over Hepatitis A 2Health News:Marler Clark, Washington Resident Sue Townsend Farms Over Hepatitis A 3Health News:MadgeTech, Inc. Introduces the New Temp1000IS Intrinsically Safe High Temperature Data Logger 2Health News:Renowned Regulatory Representatives From Mainland China and Taiwan to Discuss Need for Collaboration at DIA Meeting 2
(Date:6/18/2013)... , Safinamide significantly improves ... as add-on to levodopa Safinamide is ... in fluctuating PD patients as add-on to levodopa ... ("Newron"), a research and development company focused on ... Zambon S.p.A., a pharmaceutical company strongly committed to ...
(Date:6/18/2013)... -- Valeant Pharmaceuticals International, Inc. (NYSE: VRX ... VPII Escrow Corp., a newly formed wholly owned Canadian ... approximately $3.2 billion aggregate principal amount of senior unsecured ... 2021 and in 2023, with final tranching determined at ... net proceeds from the offering, together with proceeds from ...
(Date:6/18/2013)... 2013  Intercept Pharmaceuticals, Inc.  (NASDAQ: ICPT ... development and commercialization of novel bile acid therapeutics to ... an underwritten public offering of 1,730,000 shares of its ... per share.  In addition, Intercept has granted the underwriters ... 259,500 shares of common stock. All of ...
Breaking Medicine Technology:Safinamide Phase III Study Results Presented at 2013 MDS Meeting 2Safinamide Phase III Study Results Presented at 2013 MDS Meeting 3Safinamide Phase III Study Results Presented at 2013 MDS Meeting 4Safinamide Phase III Study Results Presented at 2013 MDS Meeting 5Safinamide Phase III Study Results Presented at 2013 MDS Meeting 6Valeant Pharmaceuticals Announces Launch Of Private Offering Of Senior Notes 2Valeant Pharmaceuticals Announces Launch Of Private Offering Of Senior Notes 3Intercept Pharmaceuticals Announces Pricing of Public Offering of Common Stock 2
Cached News: